← Back to directory

Harry J.M. Groen

Researcher Next ID · RN-033673

Researcher · Biochemistry, Genetics and Molecular Biology

University Medical Center Groningen

Groningen, Netherlands

Accepting doctoral researchersFunding unknown
Works count
927
Citation count
41,604
H-index
89
i10-index
387

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Lung Cancer Treatments and Mutations
Lung Cancer Diagnosis and Treatment
Lung Cancer Research Studies
Cancer Immunotherapy and Biomarkers
Cancer Genomics and Diagnostics

Publications

  • Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

    New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1911793

  • Immune microenvironment composition in non‐small cell lung cancer and its association with survival

    Clinical & Translational Immunology · 2020 · https://doi.org/10.1002/cti2.1142

  • Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer

    New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2002787

  • Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial

    The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30679-4

  • Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis

    Nature Genetics · 2017 · https://doi.org/10.1038/ng.3752

  • Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK -Rearranged Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2

    Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.65.5936

  • Complication rates of CT-guided transthoracic lung biopsy: meta-analysis

    European Radiology · 2016 · https://doi.org/10.1007/s00330-016-4357-8

  • Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

    The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)30146-2

  • Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

    The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)00077-2

  • Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

    The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)70168-3

  • Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening

    The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70389-4

  • Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial

    American Journal of Respiratory and Critical Care Medicine · 2013 · https://doi.org/10.1164/rccm.201209-1651oc

  • Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)

    Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2012.42.3749

  • Unraveling the Regulatory Mechanisms Underlying Tissue-Dependent Genetic Variation of Gene Expression

    PLoS Genetics · 2012 · https://doi.org/10.1371/journal.pgen.1002431

  • Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Nature Genetics · 2012 · https://doi.org/10.1038/ng.2396

  • Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor

    Annals of Oncology · 2012 · https://doi.org/10.1093/annonc/mds138

  • Trans-eQTLs Reveal That Independent Genetic Variants Associated with a Complex Phenotype Converge on Intermediate Genes, with a Major Role for the HLA

    PLoS Genetics · 2011 · https://doi.org/10.1371/journal.pgen.1002197

  • Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

    Cancer Discovery · 2011 · https://doi.org/10.1158/2159-8274.cd-11-0005

  • Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

    Science Translational Medicine · 2010 · https://doi.org/10.1126/scitranslmed.3001451

  • Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction

    Nature Genetics · 2010 · https://doi.org/10.1038/ng.716

  • Multiple common variants for celiac disease influencing immune gene expression

    Nature Genetics · 2010 · 10.1038/ng.543

  • Management of Lung Nodules Detected by Volume CT Scanning

    New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0906085

  • Thymic epithelial tumours: A population-based study of the incidence, diagnostic procedures and therapy

    European Journal of Cancer · 2007 · https://doi.org/10.1016/j.ejca.2007.11.004

  • Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.

    PubMed · 2003

Current projects

    No projects listed.